A borderline significant decrease in CVD risk was observed in subjects with cholesterol levels ≥200 mg/dL (HR additve = 0.77, 95% CI: 0.58 to 1.03) in the EPIC-Potsdam study.
← all excerpts
Microsomal triglyceride transfer protein -164 T > C gene polymorphism and risk of cardiovascular disease: results from the EPIC-Potsdam case-cohort study.
1
—
—